CASR and neoplasm: In contrast to the expression of CaSR protein in tumor specimens with a 1.5-fold higher value (median) in patients with bone metastases compared to those without metastases, FACS analyses of primary cells showed a significant (p = 0.006) 3.9-fold higher value.